|Videos|February 27, 2023
Ascendia Pharmaceuticals - Sophisticated Formulations from Molecule to Formulation to Clinical
Author(s)Ascendia Pharma
Key Learning Objectives
- Ascendia is a specialty CDMO for biologicals and gene deliveries, as well as small molecules
- Ascendia is expert in sophisticated formulations, and well as cGMP sterile and non-sterile clinical trial and commercial manufacturing
- Ascendia is expanding its manufacturing capability to best serve customers and continue to be Partner of Choice for many of them
Related Content
Trending on Pharmaceutical Technology
1
Mature Medicines Divestment Signals Shift in Manufacturing Strategy
2
CPHI Milan 2026: AI and Bioavailability, Part 1
3
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
4
Driving Quality Culture to Manage Risk: Lessons from an FDA Inspection Response
5